Bayer AG PK (BAYRY)
Bayer AG PK is an ADR representing common stock of Bayer Aktiengesellschaft, listed on OTC Markets. The underlying issuer is a life science company with operations across Europe, the Middle East, Africa, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. Bayer operates through three business segments: Pharmaceuticals, Consumer Health, and Crop Science. Its pharmaceutical business includes prescription medicines in cardiology and women’s health, specialty therapies in oncology, hematology, and ophthalmology, as well as diagnostic imaging products, contrast agents, and cell and gene therapy. The Consumer Health segment sells over-the-counter medicines and products for nutrition, allergies, cough and cold, dermatology, pain management, cardiovascular risk prevention, and digestive health. Crop Science supplies chemical and biological crop protection products, seeds, improved plant traits, digital tools, and pest and weed management solutions. Bayer was founded in 1863 and is based in Leverkusen, Germany.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-BAYR.Y
|
$14.28
|
5.5% Upside
|
Fair
|
$15.22
|
12.4% Upside
|
Fair
|
Good
|
—
|
—
|
0.02
|
0.2%
|
August 4, 2026
|
-21.6x
|
1.6x
|
1.0x
|
53.088 B
|
87.774 B
|
45.5%
|
100.0%
|
4.6
|
-5.0%
|
-122.5%
|